ACADIA Pharmaceuticals Inc (ACAD)

16.07 ↓0.15 (-0.92%)
As of August 30, 2024, 3:59pm EST.

ACAD Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $14.62 - $31.77
  • Market Capitalization: $2.69B
  • Short Percentage: 8.69%
  • Target Price: $25.28
  • Shares Outstanding: 165.88M
  • Next Earnings: Nov 30
View More Stats

Catalysts

DateCategoryCatalyst
2022-02-23
Earnings

ACAD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $25.30 Close: -2.41% Next Day: +2.06% Next Week: -2.53% View More
0 Comments Share
2022-05-04
Earnings

ACAD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $19.95 Close: -0.30% Next Day: -5.61% Next Week: -23.36% View More
0 Comments Share
2022-08-03
Earnings

ACAD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $15.38 Close: -2.67% Next Day: +1.56% Next Week: +5.01% View More
0 Comments Share
2022-11-02
Earnings

ACAD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $15.67 Close: +1.66% Next Day: -5.42% Next Week: -4.53% View More
0 Comments Share
2022-11-09
Earnings

ACAD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $15.21 Close: -1.64% Next Day: +7.96% Next Week: -0.13% View More
0 Comments Share
2023-02-27
Earnings

ACAD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $19.14 Close: +1.36% Next Day: +8.10% Next Week: +7.78% View More
0 Comments Share
2023-05-03
Earnings

ACAD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $21.46 Close: -1.21% Next Day: +0.42% Next Week: +0.89% View More
0 Comments Share
2023-08-07
Earnings

ACAD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $27.17 Close: -1.36% Next Day: -1.66% Next Week: +3.09% View More
0 Comments Share
2023-11-01
Earnings

ACAD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $22.67 Close: +1.10% Next Day: +1.41% Next Week: +2.29% View More
0 Comments Share
2024-02-26
Earnings

ACAD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $24.67 Close: +4.99% Next Day: +6.85% Next Week: -3.73% View More
0 Comments Share
2024-05-06
Earnings

ACAD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $17.15 Close: -0.87% Next Day: +0.58% Next Week: -11.49% View More
0 Comments Share
Help your fellow traders

Company Info

Stock Details

  • Current Price: $16.07
  • 52-Week Low: $14.62
  • 52-Week High: $31.77
  • Most Recent Quarter: 2024-06-30
  • Shares Float: 108.46M
  • Shares Outstanding: 165.88M
  • Market Capitalization: $2.69B
  • Next Earnings Date: 0000-00-00

Short Interest

  • Shares Short
    (Today):     0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):     0
  • Short Interest: 8.69%

The short interest for ACADIA Pharmaceuticals Inc is at 8.69%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: -0.43%
Insiders: 0.54%
Instutitions: 99.89%

Analyst Target Price

25.28

ACADIA Pharmaceuticals Inc is currently $9.06 below Wallstreet Analysts' price target.

Yesterday's Volume

857,217

Interest in ACADIA Pharmaceuticals Inc has been trending down. The average daily volume in the past 14 days is 1,349,604.

Discussions

Please log in or register to share your thoughts.

StocksOverBTC116/21/24 08:01am

$ACAD TRUST THE PROCESS! BUY AND HOLD! OUR TIME IS COMING$$$

0 Like Report
im_drank3/3/24 11:44pm

$ACAD still waiting to short this. Next Tuesday feels right for some reason

0 Like Report